July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is once ...
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...
February 3, 2016 — Abbott and Alere Inc. announced a definitive agreement for Abbott to acquire Alere. Under the terms ...
December 16, 2014 — Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio ...
July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of ...